Avoidance and management of adverse reactions to antituberculosis drugs
- PMID: 7741981
- DOI: 10.2165/00002018-199512010-00001
Avoidance and management of adverse reactions to antituberculosis drugs
Abstract
Potent antibiotics are required to cure tuberculosis and reduce the burden of illness in the community. Minor adverse effects are commonly encountered and can be managed by reassurance and explanation. Significant hypersensitivity reactions require cessation of all antituberculosis drugs. Adverse effects should be treated appropriately. An effective antituberculosis regimen should be reestablished as soon as possible. Desensitisation may be necessary if suitable alternative drugs cannot be used. In the event of drug-induced hepatitis, all hepatotoxic drugs should be ceased until symptoms resolve and liver function tests return to normal. Other significant direct toxic effects should be promptly detected and appropriately treated. A thorough knowledge of potential adverse reactions and pharmacokinetics is essential for any physician using antituberculosis drugs.
Similar articles
-
Antituberculosis drugs: drug interactions, adverse effects, and use in special situations. Part 1: first-line drugs.J Bras Pneumol. 2010 Sep-Oct;36(5):626-40. doi: 10.1590/s1806-37132010000500016. J Bras Pneumol. 2010. PMID: 21085830 Review. English, Portuguese.
-
Antituberculosis drugs: drug interactions, adverse effects, and use in special situations. Part 2: second line drugs.J Bras Pneumol. 2010 Sep-Oct;36(5):641-56. doi: 10.1590/s1806-37132010000500017. J Bras Pneumol. 2010. PMID: 21085831 Review. English, Portuguese.
-
[Management of adverse effects with antituberculosis chemotherapy].Kekkaku. 2011 Feb;86(2):87-99. Kekkaku. 2011. PMID: 21404653 Japanese.
-
Immediate-type hypersensitivity reactions due to antituberculosis drugs: a successful readministration protocol.Ann Allergy Asthma Immunol. 2015 Jul;115(1):39-44. doi: 10.1016/j.anai.2015.04.015. Epub 2015 May 14. Ann Allergy Asthma Immunol. 2015. PMID: 25981840
-
Antituberculosis drugs and hepatotoxicity.Respirology. 2006 Nov;11(6):699-707. doi: 10.1111/j.1440-1843.2006.00941.x. Respirology. 2006. PMID: 17052297 Review.
Cited by
-
Mass spectrometry for therapeutic drug monitoring of anti-tuberculosis drugs.Clin Mass Spectrom. 2018 Oct 19;14 Pt A:34-45. doi: 10.1016/j.clinms.2018.10.002. eCollection 2019 Sep. Clin Mass Spectrom. 2018. PMID: 34934812 Free PMC article. Review.
-
Alcohol use and the management of multidrug-resistant tuberculosis in Tomsk, Russian Federation.Int J Tuberc Lung Dis. 2012 Jul;16(7):891-6. doi: 10.5588/ijtld.11.0795. Epub 2012 Apr 9. Int J Tuberc Lung Dis. 2012. PMID: 22507895 Free PMC article.
-
A case report. Rediscovering tuberculostatics drugs: skin rash and pyrazinamide.Rev Esp Quimioter. 2022 Apr;35(2):295-298. doi: 10.37201/req/157.2021. Epub 2022 Mar 1. Rev Esp Quimioter. 2022. PMID: 35229590 Free PMC article. No abstract available.
-
Adverse reactions due to directly observed treatment strategy therapy in Chinese tuberculosis patients: a prospective study.PLoS One. 2013 Jun 4;8(6):e65037. doi: 10.1371/journal.pone.0065037. Print 2013. PLoS One. 2013. PMID: 23750225 Free PMC article. Clinical Trial.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical